Abstract
Extracellular matrix (ECM) degrading matrix metalloproteinases (MMPs) lead to ECM turnover, a key event in cancer growth and progression. The tissue inhibitors of matrix metalloproteinases (TIMPs) limit the activity of MMPs, which suggests their use for cancer gene therapy. Here we report that systemic administration of naked TIMP-4 DNA significantly inhibited Wilms' tumor growth in nude mice. TIMP-4, whose expression was lost in Wilms' tumor, inhibited the growth of G401 Wilms' tumor cells at a concentration lower than those required for MMP inhibition. This inhibition was associated with internalization of exogenous recombinant TIMP-4. Electroporation-mediated intramuscular injection of TIMP-4 expression plasmid resulted in sustained plasma TIMP-4 levels and significant tumor suppression. Our data demonstrate a tumor suppressive effect of TIMP-4 against Wilms' tumor and the potential utility of intramuscular delivery of TIMP gene for treatment of kidney derived cancers.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Aihara H, Miyazaki J . 1998 Nat. Biotechnol. 16: 867–870
Baccalao R, Kiai K, Jesaitis L . 1995 In Handbook of Biological Confocal Microscopy, 2nd edn. Pawley JB (ed) Plenum Press: New York pp. 311–325
Baker AH, Zaltsman AB, George SJ, Newby AC . 1998 J. Clin. Invest. 101: 1478–1487
Basset P, Bellocq JP, Wolf C, Stoll I, Hutin P, Limacher JM, Podhajcer OL, Chenard MP, Rio MC, Chambon P . 1990 Nature 348: 699–704
Bernhard EJ, Gruber SB, Muschel RJ . 1994 Proc. Natl. Acad. Sci. USA 91: 4293–4297
Bertaux B, Hornebeck W, Eisen AZ, Dubertret L . 1991 J. Invest. Dermatol. 97: 679–685
Bian J, Wang Y, Smith MR, Kim H, Jacobs C, Jackman J, Kung HF, Colburn NH, Sun Y . 1996 Oncogenesis 17: 1805–1811
Bigg HF, Shi YE, Liu YE, Steffensen B, Overall CM . 1997 J. Biol. Chem. 272: 15496–15500
Blezinger P, Wang J, Gondo M, Quezada A, Mehrens D, French M, Singhal A, Sullivan S, Rolland A, Ralston R, Min W . 1999 Nat. Biotechnol. 17: 343–348
Butler GS, Butler MJ, Atkinson SJ, Will H, Tamura T, van Westrum SS, Crabbe T, Clements J. d'Ortho MP, Murphy G . 1998 J. Biol. Chem. 273: 871–880
Fernandez-Catalan C, Bode W, Huber R, Turk D, Calvete JJ, Lichte A, Tschesche H, Maskos K . 1998 EMBO J. 17: 5238–5248
Francini G, Gonnelli S, Petrioli R, Bruni S, Marsili S, Aquino A, Camporeale A . 1993 Cancer Epidemiol. Biomarkes Prev. 2: 125–129
Garvin AJ, Re GG, Tarnowski BI, Hazen-Martin DJ, Sens DA . 1993 Am. J. Pathol. 142: 375–380
Greene J, Wang M, Liu YE, Raymond LA, Rosen C, Shi YE . 1996 J. Biol. Chem. 271: 30375–30380
Hayakawa T, Yamashita K, Ohuchi E, Shinagawa A . 1994 J. Cell Sci. 107: 2373–2379
Hayakawa T, Yamashita K, Tanzawa K, Uchijima E, Iwata K . 1992 FEBS Lett. 298: 29–32
Heppner KJ, Matrisian LM, Jensen RA, Rodgers WH . 1996 Am. J. Pathol. 149: 273–282
Imren S, Kohn DB, Shimada H, Blavier L, DeClerck YA . 1996 Cancer Res. 56: 2891–2895
Jiang Y, Wang M, Celiker MY, Liu YE, Goldberg ID, Shi YE . 2001 Cancer Res. 61: 2365–2370
Khokha R . 1994 J. Natl. Cancer Inst. 86: 299–304
Khokha R, Waterhouse P, Yagel S, Lala PK, Overall CM, Norton G, Denhardt DT . 1989 Science 243: 947–950
Liu YE, Wang M, Greene J, Su J, Ullrich S, Li H, Sheng S, Alexander P, Sang QA, Shi YE . 1997 J. Biol. Chem. 272: 20479–20483
Mohanam S, Wang SW, Rayford A, Yamamoto M, Sawaya R, Nakajima M, Liotta LA, Nicolson GL, Steler-Stevenson WG, Rao JS . 1995 Clin. Exp. Metastasis 13: 57–62
Montgomery AM, Mueller BM, Reisfeld RA, Taylor SM, DeClerck YA . 1994 Cancer Res. 54: 5467–5473
Nemeth JA, Rafe A, Steiner M, Goolsby CL . 1996 Exp. Cell Res. 24: 110–115
Pyke C, Ralfkiaer E, Tryggvason K, Dano K . 1993 Am. J. Pathol. 142: 359–365
Ritter LM, Garfield SH, Thorgeirsson UP . 1999 Biochem. Biophys Res. Commun. 257: 494–499
Tripathy SK, Svensson EC, Black HB, Goldwasser E, Margalith M, Hobart PM, Leiden JM . 1996 Proc. Natl. Acad. Sci. USA 93: 10876–10880
Wang M, Liu YE, Greene J, Sheng S, Fuchs A, Rosen EM, Shi YE . 1997 Oncogene 14: 2767–2774
Watanabe M, Takahashi Y, Ohta T, Mai M, Sasaki T, Seiki M . 1996 Cancer 77: 1676–1680
Wolff JA, Malone RW, Williams P, Chong W, Acsadi G, Jani A, Felgner PL . 1990 Science 247: 1465–1468
Xiao G, Liu YE, Gentz R, Sang QA, Ni J, Goldberg ID, Shi YE . 1999 Proc. Natl. Acad. Sci. USA 96: 3700–3705
Zucker S, Drews M, Conner C, Foda HD, DeClerck YA, Langley KE, Bahou WF, Docherty AJ, Cao J . 1998 J. Biol. Chem. 273: 1216–1222
Acknowledgements
Supported in part by grant CA68064-01 from National Institutes of Health and a fellowship grant from Long Island Jewish Medical Center to MY Celiker.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Çeliker, M., Wang, M., Atsidaftos, E. et al. Inhibition of Wilms' tumor growth by intramuscular administration of tissue inhibitor of metalloproteinases-4 plasmid DNA. Oncogene 20, 4337–4343 (2001). https://doi.org/10.1038/sj.onc.1204508
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1204508
Keywords
This article is cited by
-
EZH2-mediated epigenetic silencing of TIMP2 promotes ovarian cancer migration and invasion
Scientific Reports (2017)
-
K-Ras, H-Ras, N-Ras and B-Raf mutation and expression analysis in Wilms tumors: association with tumor growth
Medical Oncology (2017)
-
Role of Integrins in Regulating Proteases to Mediate Extracellular Matrix Remodeling
Cancer Microenvironment (2012)
-
Tissue inhibitor of metalloproteinases (TIMPs) in heart failure
Heart Failure Reviews (2012)
-
The tumor microenvironment: regulation by MMP-independent effects of tissue inhibitor of metalloproteinases-2
Cancer and Metastasis Reviews (2008)